Are psychedelics good for us? | Norman Ohler vs Joanna Moncrieff

Quick Overview

Norman Ohler argues that psychedelics like LSD are fundamentally different from addictive drugs like cocaine and should not be treated identically, citing historical use and neurological evidence, while Joanna Moncrieff counters that the current medical trend of promoting psychedelics as a replacement for conventional antidepressants is worrying because the clinical trial evidence for long-term benefits is lacking, and the focus on their supposed spiritual benefits distracts from the need for better, safer treatments.

Key Points: Norman Ohler asserts that psychedelics such as LSD are non-addictive and promote neuroplasticity, contrasting them with cocaine, which he describes as an addictive 'talking drug' associated with detrimental historical use. Ohler points to archaeological evidence, like cup residue from ancient Egypt, suggesting long-term ritualistic use of psychoactive compounds by humans, unlike Neanderthals. Joanna Moncrieff expresses concern that psychedelics are being promoted as a replacement for antidepressants (like SSRIs or benzodiazepines) without sufficient long-term evidence of benefit, calling the current approach potentially dangerous. Moncrieff notes that while some people experience positive insights from psychedelic-assisted therapy, society's normalization of their use overlooks the lack of robust, long-term clinical trial data. She highlights that the current clinical evidence does not definitively show psychedelics are superior for treating conditions like PTSD or alcoholism compared to existing methods, and their high cost makes them inaccessible for widespread, regular use. The discussion centers on the ethical and practical implications of rapidly integrating psychedelics into mainstream medical practice, contrasting the historical context of ritual use with modern therapeutic application.

Context: This video features a debate or discussion titled "Out of Our Minds," involving Norman Ohler, author of Blitzed: Drugs in the Third Reich, and Joanna Moncrieff, a psychiatrist and academic. The central theme revolves around the current surge in interest regarding the therapeutic potential of psychedelics (like LSD and psilocybin) and whether they should be integrated into medical practice, contrasting their effects and historical context with traditional addictive substances.